Solving the mystery of how cigarette smoking weakens bones

Key points
- Almost 20 years after scientists first identified cigarette smoking as a risk factor for osteoporosis and bone fractures, a new study is shedding light on exactly how cigarette smoke weakens bones.
- Gary Guishan Xiao and colleagues point out that previous studies suggested toxins in cigarette smoke weakened bones by affecting the activity of osteoblasts, cells which build new bone, and osteoclasts, which resorb, or break down, old bone.
- They discovered that human smokers produce unusually large amounts of two proteins that foster production of bone-resorbing osteoclasts compared to non-smokers.
- The authors acknowledge funding from the Cancer and Smoking Related Disease Research Program and the Nebraska Tobacco Settlement Biomedical Research Program.
Almost 20 years after scientists first identified cigarette smoking as a risk factor for osteoporosis and bone fractures, a new study is shedding light on exactly how cigarette smoke weakens bones. The report, in ACS' Journal of Proteome Research, concludes that cigarette smoke makes people produce excessive amounts of two proteins that trigger a natural body process that breaks down bone.
Gary Guishan Xiao and colleagues point out that previous studies suggested toxins in cigarette smoke weakened bones by affecting the activity of osteoblasts, cells which build new bone, and osteoclasts, which resorb, or break down, old bone. Weakening of the bones, known as osteoporosis, can increase the risk of fractures and is a major cause of disability among older people. To shed light on how cigarette smoking weakens bones, the scientists analyzed differences in genetic activity in bone marrow cells of smokers and non-smokers.
They discovered that human smokers produce unusually large amounts of two proteins that foster production of bone-resorbing osteoclasts compared to non-smokers. Experiments with laboratory mice confirmed the finding.
###
The authors acknowledge funding from the Cancer and Smoking Related Disease Research Program and the Nebraska Tobacco Settlement Biomedical Research Program.
The American Chemical Society is a nonprofit organization chartered by the U.S. Congress. With more than 164,000 members, ACS is the world's largest scientific society and a global leader in providing access to chemistry-related research through its multiple databases, peer-reviewed journals and scientific conferences. Its main offices are in Washington, D.C., and Columbus, Ohio.
To automatically receive news releases from the American Chemical Society, contact newsroom@acs.org.
###
Michael Bernstein
m_bernstein@acs.org
202-872-6042
American Chemical Society
Written and revised by
David Cohen, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Diabetes & Hormones →
NewsGestational diabetes can be prevented in high-risk women
The prevalence of overweight and obesity are increasing worldwide. Up to 60 percent of women of reproductive age are overweight or obese in the developed countries. Obesity is a risk factor for pregnancy complications…
31 July 2015
NewsDiabetes - TB link found in Australia
A 20-year study by James Cook University scientists has found a strong link between diabetes and tuberculosis in tropical Australia. Despite massive improvements in sanitation and antibiotic coverage over the last…
28 July 2015
NewsTransgender youth have typical hormone levels
Johanna Olson, MD, and her colleagues at Children's Hospital Los Angeles, provide care for the largest number of transyouth in the U.S. and have enrolled 101 patients in a study to determine the safety and efficacy of…
22 July 2015





